The joints of patients with early arthritis that showed subclinical inflammation on MRI had an increased risk of radiographic progression in the first year after disease presentation, particularly...
COEUR D’ALENE, ID. – Pediatric chronic cutaneous lupus erythematosus transforms into systemic disease in one-quarter of cases, and if it’s going to do so, it’ll typically be within the first year...
COEUR D’ALENE, ID. – Pediatric chronic cutaneous lupus erythematosus transforms into systemic disease in one-quarter of cases, and if it’s going to do so, it’ll typically be within the first year...
PARIS – The live birth rate among women taking belimumab for systemic lupus erythematosus is similar to the background rate for women with the disorder, a study showed.
An analysis of clinical...
PARIS – The live birth rate among women taking belimumab for systemic lupus erythematosus is similar to the background rate for women with the disorder, a study showed.
An analysis of clinical...
PARIS – A set of genetic polymorphisms is beginning to allow researchers to predict which patients with rheumatoid arthritis will have a severe disease course, as well as determine their response to...
Tofacitinib was superior to methotrexate at reducing the signs and symptoms of rheumatoid arthritis, improving physical function, and slowing the progression of joint damage in a 2-year, phase III...
Spondyloarthritis patients with microscopic gut inflammation had to start anti–tumor necrosis factor treatment sooner in the course of their disease than patients without gut inflammation in a...
PARIS – Rheumatoid arthritis patients who received the interleukin-6–blocking drug sarilumab plus methotrexate had significantly better short-term and 1-year outcomes than did patients on...